C-reactive protein is a bystander of cardiovascular disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20675658.
- Also identified by DOI 10.1093/eurheartj/ehq242.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A large number of studies have evaluated the association of hs-C-reactive protein with atherosclerosis and coronary heart disease (CHD) in mechanistic, genetic, population-based studies, as well as clinical trials. This paper reviews the collective evidence to determine if hs-C-reactive protein is part of the causal pathway of atherosclerosis and CHD or whether it is a bystander.
Medical subject headings
- Atherosclerosis
- C-Reactive Protein
- Coronary Disease